课题基金 / 基金详情

Development of HDL-raising drugs targeting ABCA1

Development of HDL-raising drugs targeting ABCA1
开发针对 ABCA1 的 HDL 升高药物
批准号:
21790739
负责人:
IWAMOTO Noriyuki
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010

项目摘要

项目成果

IWAMOTO Noriyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABCA1 expression is regulated negatively by a transcriptional factor AP2 and its protein level is modulated by calpain-mediated proteolytic degradation. In this research project, I demonstrated that regulation of the ABCA1 gene by AP2 is mediated by its phosphorylation by PKD, which is similar to negative regulation of the adiponectin gene. I also showed that calmodulin binds ABCA1 and suppress its calpain-mediated degradation. A calmodulin inhibitor W7 enhanced calmodulin binding to ABCA1 to increase HDL biogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊: Atheroscler.
影响因子: --
作者: [Noriyuki Iwamoto, Shinji Yokoyama]
通讯作者: Shinji Yokoyama
FGF-1 induces expression of LXRalpha and production of 25-hydroxy cholesterol to up-regulate apoE gene transcription in rat astrocytes
FGF-1 诱导 LXRα 表达和 25-羟基胆固醇产生,上调大鼠星形胶质细胞中 apoE 基因转录
DOI: --
发表时间: 2009
期刊: The Journal of Lipid Research 50
影响因子: --
作者: [呂鋭、岩本紀之, 他]
通讯作者:
Calmodulin interacts with ABCA1 and regulate its expression level.
钙调蛋白与 ABCA1 相互作用并调节其表达水平。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Noriyuki Iwamoto, Shinji Yokoyama, 岩本紀之, 岩本紀之, 岩本紀之, 岩本紀之]
通讯作者: 岩本紀之
Pharmaoological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis
ABCA1 降解的药理学抑制可增加 HDL 生物合成并具有抗动脉粥样硬化作用
DOI: --
发表时间: 2009
期刊: The Journal of Lipid Research 50
影响因子: --
作者: [荒川礼二郎、岩本紀之, 他]
通讯作者:
9
    Development of increasing functional HDL-C using antisense oligonucleotides as innovative therapy
    海外基金